Paul Abrahamse
Overview
Explore the profile of Paul Abrahamse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veenstra C, Abrahamse P, Hamilton A, Ward K, Gomez S, Liu L, et al.
J Clin Oncol
. 2025 Feb;
:JCO2402442.
PMID: 40020204
Purpose: Oncologists encounter patients with pathogenic variants (PVs) in , , or , but little is known about their cancer mortality. Methods: Patients who were 20 years or older, diagnosed...
2.
Katz S, Abrahamse P, Hofer T, Courser R, Hodan R, Tocco R, et al.
BMC Cancer
. 2025 Feb;
25(1):366.
PMID: 40016666
Background: There is pressing need to develop and evaluate clinically sound approaches to supporting the engagement between patients who have inherited cancer susceptibility and their relatives who may share it....
3.
Katz S, Abrahamse P, Furgal A, Hodan R, Tocco R, Ward K, et al.
J Clin Oncol
. 2024 Jul;
42(26):3123-3129.
PMID: 39008790
Purpose: To examine receipt of genetic testing and communication with relatives about results into survivorship after diagnosis of breast cancer. Methods: Women age 20-79 years diagnosed with early-stage breast cancer...
4.
Dualeh S, Anderson M, Abrahamse P, Kamdar N, Evans E, Suwanabol P
Ann Surg
. 2024 Feb;
281(4):682-688.
PMID: 38390769
Objective: To examine trends in end-of-life care services and satisfaction among veterans undergoing any inpatient surgery. Background: The Veterans Health Administration has undergone system-wide transformations to improve end-of-life care yet...
5.
Mullins M, Atluri N, Abrahamse P, Radhakrishnan A, Hamilton A, Ward K, et al.
Breast Cancer Res Treat
. 2023 Jun;
200(3):391-398.
PMID: 37296280
Purpose: Little is known about the factors contributing to the receipt of non-recommended surveillance testing among early-stage breast cancer survivors. We assessed primary care providers (PCP) attitudes about and tendency...
6.
Kurian A, Abrahamse P, Furgal A, Ward K, Hamilton A, Hodan R, et al.
JAMA
. 2023 Jun;
330(1):43-51.
PMID: 37276540
Importance: Germline genetic testing is recommended by practice guidelines for patients diagnosed with cancer to enable genetically targeted treatment and identify relatives who may benefit from personalized cancer screening and...
7.
Ghazal L, Abrahamse P, Ward K, Morris A, Hawley S, Veenstra C
JAMA Netw Open
. 2023 Apr;
6(4):e235897.
PMID: 37022684
Importance: Partners of colorectal cancer (CRC) survivors play a critical role in diagnosis, treatment, and survivorship. While financial toxicity (FT) is well documented among patients with CRC, little is known...
8.
Katz S, Abrahamse P, Hodan R, Kurian A, Rankin A, Tocco R, et al.
JCO Oncol Pract
. 2023 Mar;
19(6):e848-e858.
PMID: 36921235
Purpose: Cascade genetic risk evaluation in families with hereditary cancer can reduce the burden of disease but the rate of germline genetic testing in relatives of patients at risk is...
9.
Veenstra C, Ellis K, Abrahamse P, Ward K, Morris A, Hawley S
BMC Cancer
. 2022 Oct;
22(1):1060.
PMID: 36229796
Background: We investigated whether partner (spouse or intimate partner) engagement in colorectal cancer (CRC) surveillance is associated with patient receipt of surveillance. Methods: From 2019 to 2020 we surveyed Stage...
10.
Kurian A, Abrahamse P, Hamilton A, Caswell-Jin J, Gomez S, Hofer T, et al.
JNCI Cancer Spectr
. 2022 Jun;
6(4).
PMID: 35723570
Background: Genetic testing is widespread among breast cancer patients; however, no guideline recommends using germline genetic testing results to select a chemotherapy regimen. It is unknown whether breast cancer patients...